Inka Zornig
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Neoadjuvant Atezolizumab and Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer: Efficacy and Safety Results of an Open-Label, Single-Arm, Phase II Trial.
Journal: International journal of cancer
Published: January 17, 2026
ESPEC-SUIT: a versatile and robust platform to identify and track antigen-specific T cell receptors in patients with cancer.
Journal: Journal for immunotherapy of cancer
Published: July 30, 2025
Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: results of the NEOMUN trial.
Journal: Journal for immunotherapy of cancer
Published: July 07, 2025
Confocal Raman microspectroscopy for spatially resolved tissue characterisation of disease-linked spectra-pathological signatures.
Journal: Clinical and translational medicine
Published: June 17, 2025
Computational workflows for natural and biomedical image processing based on hypercomplex algebras.
Journal: Patterns (New York, N.Y.)
Published: May 13, 2025
Neo-antigen tumor vaccination depends on CD4-licensing conveyed by adeno-associated virus like particles.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 13, 2025
Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination site.
Journal: Oncoimmunology
Published: February 04, 2025
Reversal of Endothelial Cell Anergy by T Cell-Engaging Bispecific Antibodies.
Journal: Cancers
Published: September 29, 2024
optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input Material.
Journal: Molecular & cellular proteomics : MCP
Published: April 26, 2024
Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.
Journal: Breast cancer research : BCR
Published: April 02, 2024
Novel chimeric antigen receptors for the effective and safe treatment of NY-BR-1 positive breast cancer.
Journal: Clinical and translational medicine
Published: February 29, 2024
Last Updated: 09/26/2026